Fig. 3From: In silico analysis of binding interaction of conantokins with NMDA receptors for potential therapeutic use in Alzheimer’s disease a NMDAR in humans (red) active residues highlighted in green. b NMDAR in rats (blue) residues aligned with residues of NMDAR in humans highlighted in white. c Conserved residues shown in sequence alignment between the NMDA receptor in rats (above) and humans (below)Back to article page